---
title: "Why this pharma pro likes Johnson & Johnson, Eli Lilly, and Merck stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302593949.md"
description: "Despite rising interest rates and the uncertainty of midterm elections, Asad Haider of Goldman Sachs sees promise in Big Pharma and biotech."
datetime: "2026-10-21T17:32:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302593949.md)
  - [en](https://longbridge.com/en/news/302593949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302593949.md)
generator: "portal-rs"
---

# Why this pharma pro likes Johnson & Johnson, Eli Lilly, and Merck stock

Despite rising interest rates and the uncertainty of midterm elections, Asad Haider of Goldman Sachs sees promise in Big Pharma and biotech.

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)

## Related News & Research

- [Eli Lilly and Company $LLY Shares Sold by Essential Planning LLC.](https://longbridge.com/en/news/302956671.md)
- [Merck & Co Says FDA Accepts Priority Review For SAC-TMT Biologics License Application](https://longbridge.com/en/news/303113310.md)
- [Eli Lilly and Company $LLY Shares Sold by USAdvisors Wealth Management LLC](https://longbridge.com/en/news/302964762.md)
- [Correction to Eli Lilly's Omvoh Hits Goal in Phase 3 Study Article on Oct. 19](https://longbridge.com/en/news/302438751.md)
- [Eli Lilly and Co Stock (LLY) Opened Up by 5.01% on Oct 20: A Full Analysis](https://longbridge.com/en/news/302432875.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**